Your browser doesn't support javascript.
loading
Aetiology of pancytopenia: Experience of a South African tertiary academic centre
Nell, Erica-Mari; Zivanai C, Chapanduka.
Affiliation
  • Nell, Erica-Mari; 1Division of Haematological Pathology, Department of Pathology, Faculty of Medicine and Health Sciences. National Health Laboratory Service, Tygerberg Hospital. Cape Town,. ZA
  • Zivanai C, Chapanduka; Division of Haematological Pathology, Department of Pathology, Faculty of Medicine and Health Sciences. National Health Laboratory Service, Tygerberg Hospital. Cape Town. ZA
Afr. j. lab. med. (Print) ; 11(1): 1-8, 2022.
Article in En | AIM | ID: biblio-1378699
Responsible library: CG1.1
ABSTRACT

Background:

Pancytopenia is a manifestation of numerous disease entities. The causes of pancytopenia differ with geographic region, socio-economic factors and HIV prevalence. Awareness of the common causes of pancytopenia may aid timely diagnosis.

Objective:

This study aimed to determine the aetiology of pancytopenia in a South African population.

Methods:

A retrospective observational study of adult patients presenting with pancytopenia at Tygerberg Academic Hospital, South Africa, from January 2016 to December 2017 was performed. Data on pancytopenia cases were obtained from the laboratory information system and utilised to determine the causes of pancytopenia.

Results:

A total of 673 cases of pancytopenia were identified. The most common causes of pancytopenia were chemoradiation therapy (25%), sepsis (18%), haematological malignancy (9%), advanced HIV (7%), and megaloblastic anaemia (6%). The diagnostic yield of bone marrow examinations (BME) was 57% (n = 52/91). The aetiology of pancytopenia differed according to age, with malignancy being a more common cause of pancytopenia among the elderly.

Conclusion:

Several easily recognisable and treatable conditions can manifest as pancytopenia. Prompt management of such conditions, notably sepsis and megaloblastic anaemia, can result in the resolution of the cytopenias and negate the need for a BME. However, haematological malignancy and unexplained pancytopenia strongly rely on a BME to establish a diagnosis. Pancytopenia investigations, when guided by appropriate clinic-laboratory findings, can promptly identify the underlying aetiology, while also identifying cases where an expedited BME is required. This is valuable in resource-conscious medicine
Subject(s)
Key words
Full text: 1 Main subject: Pancytopenia / Anemia, Megaloblastic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Afr. j. lab. med. (Print) Year: 2022 type: Article
Full text: 1 Main subject: Pancytopenia / Anemia, Megaloblastic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Afr. j. lab. med. (Print) Year: 2022 type: Article